Next Article in Journal
Sclerotherapy of Vascular Malformations in the Oral Cavity—Minimizing Postoperative Morbidity
Previous Article in Journal
Phacoemulsification Induced Changes of Choroidal Thickness in Eyes with Age-Related Macular Degeneration
Open AccessArticle

The Diagnostic–Therapeutic Care Pathway in Psoriasis: Towards ISO 9001:2015 Certification

1
AOU Maggiore della Carità, 28100 Novara, Italy
2
Department of Health Science, University of Eastern Piedmont, 28100 Novara, Italy
3
OPT, Consulenza di Direzione, 20159 Milano, Italy
*
Author to whom correspondence should be addressed.
These authors equally contribute to this work.
Medicina 2020, 56(5), 253; https://doi.org/10.3390/medicina56050253
Received: 22 April 2020 / Revised: 18 May 2020 / Accepted: 20 May 2020 / Published: 22 May 2020
(This article belongs to the Special Issue New Perspectives in the Treatment of Non-melanoma Skin Cancer)
Background and objectives: Psoriasis (Pso) is a common skin condition characterized by a strong psychosocial impact, and is nowadays accepted as a systemic immune-mediated inflammatory disease. Diagnostic–Therapeutic Care Pathways (DTCPs) represent a predefined sequence of diagnostic, therapeutic, and assistance activities that integrate the participation of several specialists to obtain, for each patient, the correct diagnosis and thus the most appropriate therapy. A DTCP was validated in our dermatology clinic (AOU Maggiore della Carità, Novara, Italy). The validation process included the detailed elaboration of a protocol of diagnosis, staging of care, therapies, and follow-up of the patient with Pso. The formalization and adaptation of our DTCP resulted in ISO 9001: 2015 certification in May 2019. Materials and methods: This process involved several stages, including analysis of context and the identification of (i) targets, (ii) indicators, and (iii) service providers. The evaluation was based on a cohort of over 200 patients affected by moderate to severe Pso, who were treated and followed-up at our institution from September 2017 to April 2019. Results: The ISO 9001:2015 quality certification process allowed us to identify our weaknesses, i.e., the long waiting times for the first visit and the reduced physician–patient ratio, but also our strengths, such as the commitment to clinical research, effective collaboration with other specialists, the efficient use of technological and human resources, and attention to ensuring patient follow-up. Conclusions: In qualifying for and achieving the ISO Quality Management System (QMS) certification we were heartened to realize that our basic methodology and approach were fit for purpose. The implementation of the ISO QMS helped us to reorganize our priorities by placing the patient at the center of the process and raising awareness that Pso is not just a skin disease. View Full-Text
Keywords: diagnostic–therapeutic care pathway; ISO 9001:2015 certification; quality management system; psoriasis; quality improvement diagnostic–therapeutic care pathway; ISO 9001:2015 certification; quality management system; psoriasis; quality improvement
Show Figures

Figure 1

MDPI and ACS Style

Veronese, F.; Graziola, F.; Cammarata, E.; Andreassi, M.; Mazzoletti, V.; Taglietti, C.; Navarra, G.; Savoia, P.; Tiberio, R. The Diagnostic–Therapeutic Care Pathway in Psoriasis: Towards ISO 9001:2015 Certification. Medicina 2020, 56, 253.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop